News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Clinical trial moves lung cancer drug closer to UK use

30/10/13

A recently approved lung cancer drug has moved closer to UK clinical use after ICR researchers provided the latest confirmation of its safety.
ICR Logo
ICR imaging research part of £35m funding boost

24/10/13

CANCER imaging is set to get a major boost from a £35 million initiative to develop cutting edge imaging technologies for cancer research.
ICR Logo
Gene discovery points to immune link between cancer and multiple sclerosis

22/10/13

A genetic risk factor for multiple sclerosis (MS) has been linked to Hodgkin lymphoma, suggesting a common mechanism could be at work in the two diseases.
ICR Logo
NICE draft guidance recommends new prostate cancer drug

18/10/13

Guidance recommending ICR-developed drug enzalutamide for treating metastatic prostate cancer is welcomed as the latest in a drug development golden age.
ICR Logo
Invading cancers secrete enzyme that hijacks healthy tissue

17/10/13

Cancers secrete an enzyme allowing them to hijack the surrounding healthy tissue in order to create the right conditions for their invasion and spread, new research finds.
ICR Logo
Thalidomide therapy effective for low risk myeloma patients

16/10/13

Thalidomide therapy can extend the lives of myeloma patients, but it isn’t suitable for everyone with the disease, ICR researchers have found.
ICR Logo
'DNA tags' could guide treatment for advanced ovarian cancer

15/10/13

Chemical 'tags' on tumour DNA could help doctors decide which chemotherapy women with advanced ovarian cancer should get.
ICR Logo
Targeted treatment plus chemotherapy could benefit women with ovarian cancer

11/10/13

Chemotherapy extends lives of women with ovarian cancer when used in tandem with a new type of targeted treatment, study shows.
ICR Logo
Imaging technique could assess a tumour’s response to treatment in real time

08/10/13

New modelling technique could allow doctors to track metabolic reactions in tumours in real time, say ICR researchers.
ICR Logo
An action plan to tackle critical gaps in breast cancer research

01/10/13

Research facilitated by Breast Cancer Campaign has identified the ten critical gaps that exist in breast cancer research.
ICR Logo
Radiotherapy could spare bladder cancer patients surgery

01/10/13

Radiotherapy is an effective treatment for aggressive bladder cancer and could improve quality of life by sparing patients surgery, according to an ICR study.
ICR Logo
Ultrasound: more than just baby pictures

29/09/13

For many people, the word ‘ultrasound’ conjures up images of nurses and doctors showing grainy footage of foetuses to pregnant women. Although imaging unborn babies is undoubtedly important, the technology has an incredible array of clinical uses outside the obstetrician’s office.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.